END nucleases are antiphage defence systems targeting multiple phages with modified genomes
Nature Microbiology · 26.06.2026 · 11 (8) · 2336-2348
DOI: 10.1038/s41564-026-02407-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Microbiology, online erschienen am 26.06.2026. Verfasst von Wearn-Xin Yee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Genome, Viral, Bacteriophages, Pseudomonas Phages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Prokaryotes carry phage defence systems in 'defence islands' as immunity mechanisms; however, which systems are endogenously active against specific phages is often not known. Here we identify a single gene in a defence island that is necessary for a Pseudomonas aeruginosa cystic fibrosis isolate to block phages from the Pbunavirus family, which are commonly used as therapeutics. The causal defence system, here named END nucleases, has a Type IIS restriction endonuclease-like domain fused to a catalytically inactive endonuclease III (iEndoIII), which normally recognizes non-canonical bases to repair DNA in prokaryotes and eukaryotes. END nucleases exclusively antagonize the replication of modified phages, but they are agnostic to the modification, targeting up to eight distinct families of phages with modified DNA, with at least ten different known modifications beyond methylation. A small region of the iEndoIII domain is identified that dictates targeting specificity. Modified phages from the Pbunavirus and Wroclawvirus family (Pa5Oct-like) of jumbo phages encode direct-binding END nuclease inhibitors. This work identifies a broad modification-dependent restriction endonuclease and cognate inhibitors that can fortify phage outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.
- Research Department, New England Biolabs, Ipswich, MA, USA.
- Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
- Synthetic and Systems Biology Unit, Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary.
- Department of Microbiology and Immunology, University of California, San Francisco, CA, USA. joseph.bondy-denomy@ucsf.edu.
Förderung
- NIAID NIH HHS
Zitieren
APA
Yee, W. X., Lee, Y. J., Makarova, K. S., Klein, T. A., Wirganowicz, A., Gabagat, A. E., Liu, M., Csörgő, B., Koonin, E. V., Weigele, P. R., & Bondy-Denomy, J. (2026). END nucleases are antiphage defence systems targeting multiple phages with modified genomes. Nature Microbiology, 11(8), 2336-2348. https://doi.org/10.1038/s41564-026-02407-2
Vancouver
Yee WX, Lee YJ, Makarova KS, Klein TA, Wirganowicz A, Gabagat AE, et al. END nucleases are antiphage defence systems targeting multiple phages with modified genomes. Nature Microbiology. 2026;11(8):2336-2348. doi:10.1038/s41564-026-02407-2
BibTeX
@article{Yee2026,
author = {Yee, Wearn-Xin and Lee, Yan-Jiun and Makarova, Kira S and Klein, Timothy A and Wirganowicz, Alex and Gabagat, Andres E and Liu, Miaoxi and Csörgő, Bálint and Koonin, Eugene V and Weigele, Peter R and Bondy-Denomy, Joseph},
title = {END nucleases are antiphage defence systems targeting multiple phages with modified genomes},
journal = {Nature Microbiology},
year = {2026},
volume = {11},
number = {8},
pages = {2336--2348},
doi = {10.1038/s41564-026-02407-2}
}
EUVIMED